Alexandria Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | $6.96M | Buy |
11,505
+471
| +4% | +$285K | 0.64% | 55 |
|
2021
Q2 | $6.16M | Buy |
11,034
+5,514
| +100% | +$3.08M | 0.57% | 65 |
|
2021
Q1 | $2.61M | Buy |
5,520
+797
| +17% | +$377K | 0.26% | 104 |
|
2020
Q4 | $2.28M | Sell |
4,723
-3,369
| -42% | -$1.63M | 0.24% | 108 |
|
2020
Q3 | $4.53M | Buy |
8,092
+2,168
| +37% | +$1.21M | 0.54% | 65 |
|
2020
Q2 | $3.7M | Buy |
5,924
+3,874
| +189% | +$2.42M | 0.48% | 70 |
|
2020
Q1 | $1M | Buy |
2,050
+291
| +17% | +$142K | 0.16% | 123 |
|
2019
Q4 | $660K | Buy |
+1,759
| New | +$660K | 0.09% | 153 |
|
2017
Q4 | – | Sell |
-6
| Closed | -$3K | – | 450 |
|
2017
Q3 | $3K | Sell |
6
-6
| -50% | -$3K | ﹤0.01% | 486 |
|
2017
Q2 | $6K | Buy |
12
+2
| +20% | +$1K | ﹤0.01% | 471 |
|
2017
Q1 | $4K | Sell |
10
-409
| -98% | -$164K | ﹤0.01% | 506 |
|
2016
Q4 | $154K | Sell |
419
-3,350
| -89% | -$1.23M | 0.04% | 150 |
|
2016
Q3 | $1.52M | Sell |
3,769
-1,097
| -23% | -$441K | 0.28% | 70 |
|
2016
Q2 | $1.7M | Sell |
4,866
-3
| -0.1% | -$1.05K | 0.3% | 75 |
|
2016
Q1 | $1.76M | Buy |
4,869
+2,973
| +157% | +$1.07M | 0.32% | 70 |
|
2015
Q4 | $1.03M | Hold |
1,896
| – | – | 0.26% | 78 |
|
2015
Q3 | $882K | Sell |
1,896
-1
| -0.1% | -$465 | 0.21% | 83 |
|
2015
Q2 | $1.03M | Buy |
1,897
+1,875
| +8,523% | +$1.02M | 0.23% | 78 |
|
2015
Q1 | $10K | Sell |
22
-1
| -4% | -$455 | ﹤0.01% | 399 |
|
2014
Q4 | $9K | Sell |
23
-2
| -8% | -$783 | ﹤0.01% | 382 |
|
2014
Q3 | $9K | Buy |
25
+2
| +9% | +$720 | ﹤0.01% | 360 |
|
2014
Q2 | $6K | Buy |
23
+5
| +28% | +$1.3K | ﹤0.01% | 428 |
|
2014
Q1 | $5K | Buy |
18
+2
| +13% | +$556 | ﹤0.01% | 456 |
|
2013
Q4 | $4K | Buy |
16
+2
| +14% | +$500 | ﹤0.01% | 493 |
|
2013
Q3 | $4K | Hold |
14
| – | – | ﹤0.01% | 494 |
|
2013
Q2 | $3K | Buy |
+14
| New | +$3K | ﹤0.01% | 584 |
|